Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sugi Holdings CoSGIPF 92 EV-to-EBIT is 10.17 as of Aug. 02, 2026, which is 12% below its 10-year median of 11.50. GuruFocus rates SGIPF with a GF Score™ of 92/100 and a GF Value™ of $23.08 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Sugi Holdings Co ranks better than 71.97% on this metric.
The historical rank and industry rank for Sugi Holdings Co's EV-to-EBIT or its related term are showing as below:
SGIPF'
s EV-to-EBIT Range Over the Past 10 Years
Min: 7.41 Med: 11.5 Max: 16.73
Current: 10.59
During the past 13 years, the highest EV-to-EBIT of Sugi Holdings Co was 16.73. The lowest was 7.41. And the median was 11.50.
SGIPF's EV-to-EBIT is ranked better than 71.97% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.84
vs SGIPF: 10.59
Sugi Holdings Co (OTCPK:SGIPF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Sugi Holdings Co's Enterprise Value for the quarter that ended in Feb. 2026 was $2,837 Mil.
Sugi Holdings Co's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $303 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sugi Holdings Co EV-to-EBIT Related Terms
Sugi Holdings Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Sugi Holdings Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sugi Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sugi Holdings Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sugi Holdings Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Sugi Holdings Co's EV-to-EBIT falls into.
Sugi Holdings Co's current Enterprise Value is $3,080 Mil.
Sugi Holdings Co's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $303 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sugi Holdings Co (SGIPF) has a EV-to-EBIT of 10.17 as of Aug. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sugi Holdings Co and its competitors. This is 12% below median its historical median of 11.50. Over the past decade, Sugi Holdings Co's EV-to-EBIT has ranged from 7.41 to 16.73. According to the industry distribution chart, Sugi Holdings Co ranks #132 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 28%.
Is Sugi Holdings Co's EV-to-EBIT too high?
Sugi Holdings Co's current EV-to-EBIT of 10.17 is 12% below median its 10-year median of 11.50. Over the past 10 years, this metric has ranged from a low of 7.41 to a high of 16.73. The Healthcare Providers & Services industry median EV-to-EBIT is 15.84. Sugi Holdings Co's value of 10.17 is 35.8% below this industry median. Based on the distribution chart, Sugi Holdings Co ranks #132 out of 471 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sugi Holdings Co has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sugi Holdings Co's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sugi Holdings Co ranks #132 out of 471 companies for EV-to-EBIT. This puts Sugi Holdings Co in the upper half of its industry. The industry median EV-to-EBIT is 15.84. Sugi Holdings Co's value of 10.17 is 35.8% below this benchmark. Historically, Sugi Holdings Co's own EV-to-EBIT has ranged from 7.41 to 16.73 over the past decade. While the company's 10-year median is 11.50 vs. the industry median of 15.84, Sugi Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.84, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sugi Holdings Co's current EV-to-EBIT of 10.17 is 35.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sugi Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sugi Holdings Co's current EV-to-EBIT is 10.17, which is 12% below median its own 10-year median of 11.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sugi Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Sugi Holdings Co (SGIPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $23.08, compared to a current price of $18.99 — trading 17.7% below its estimated fair value. The current EV-to-EBIT is 10.17, which is 12% below median its 10-year median of 11.50 and 35.8% below the Healthcare Providers & Services industry median of 15.84. Sugi Holdings Co's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Sugi Holdings Co (SGIPF), the current EV-to-EBIT is 10.17 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sugi Holdings Co (SGIPF) Overvalued in 2026?
Based on GuruFocus' analysis, Sugi Holdings Co stock appears to be undervalued.
The current stock price of $18.99 is trading 17.7% below its estimated GF Value™ of $23.08.
GuruFocus considers Sugi Holdings Co to be Modestly Overvalued.
Key valuation signals for SGIPF:
EV-to-EBIT: 10.17 (12% below median its 10-year median of 11.50)
GF Value™: $23.08 vs. price of $18.99 (17.7% below fair value)
Industry Position: 35.8% below the Healthcare Providers & Services median (#132 of 471)
No single metric tells the full story. See the SGIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
92GF Score
Get the complete analysis for SGIPF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGIPF has been successfully added to your 
